New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 13, 2014
08:50 EDTEXASExact Sciences CMS approval expected by early September, says Canaccord
Canaccord met with Exact Sciences management and came away confident in the CMS' preliminary reimbursement amount, which the firm expects by early September. Canaccord also noted checks into the company's call center indicated strong interest in Cologuard and it expects targeted digital advertising to raise awareness of its product. The firm raised its price target on the stock to $21 from $20 and keeps its Buy rating on the shares.
News For EXAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2015
10:00 EDTEXASOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:56 EDTEXASExact Sciences upgraded to Buy from Hold at Lake Street
Lake Street Capital Markets analyst Bruce Jackson upgraded Exact Sciences to Buy and raised his price target for shares to $30 from $27. The company's Q2 report showed better than expected gross margins and the stock's risk/reward is appealing, Jackson tells investors.
July 21, 2015
09:21 EDTEXASOn The Fly: Pre-market Movers
Subscribe for More Information
09:13 EDTEXASExact Sciences 7M share Spot Secondary priced at $25.50
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use